BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2015
View Archived Issues
Pacific Therapeutics launches share offer
Read More
Cell Cure initiates phase I/II study of OpRegen in patients with dry AMD and geographic atrophy
Read More
Institut Pasteur Korea and Qurient report anti-TB compounds
Read More
Vaxin to acquire Immune Targeting Systems
Read More
Merck KGaA discloses new BTK inhibitors
Read More
Novartis reports SMN expression enhancers
Read More
Amarantus enters into Alzheimer's biomarker collaboration with Anavex Life Sciences
Read More
Servier and Vernalis patent novel Bcl-2 inhibitors
Read More
Metabolic Solutions Development divulges PPAR-sparing compounds
Read More
Neutrophil activation shows potential as a biomarker for ischemia and inflammation
Read More
Actavis proposes adopting Allergan as corporate name
Read More
Revlimid approved in E.U. for previously untreated multiple myeloma
Read More
MMP-12 knockdown protects BBB integrity and reduces permeability
Read More
Teva to study TV-45070 for post-herpetic neuralgia in phase IIb trial
Read More
Novel anti-HIV agent shows potential as HIV vaccine alternative
Read More
Summit initiates phase Ib modified diet trial of SMT-C1100 for Duchenne muscular dystrophy
Read More
BioNovion and Genmab establish immune oncology collaboration
Read More
Clinical milestone achieved in development of rVSV-EBOV Ebola vaccine candidate
Read More
Tambocor fine granules approved in Japan for pediatric patients
Read More
Midatech Pharma reports preclinical data on OpsiSporin sustained-release treatment for uveitis
Read More
Iconic Therapeutics starts phase II trial of hI-con1 in choroidal neovascularization
Read More
Specific inhibition of NLRP3 shows potential for the treatment of inflammatory diseases
Read More
Pfizer presents RORC2 inhibitors
Read More
New HIV protease inhibitors disclosed by Merck & Co.
Read More
CEPT inhibitors designed at Merck & Co.
Read More